| Literature DB >> 27126807 |
Elizabeth Murphy, Hossein Ardehali, Robert S Balaban, Fabio DiLisa, Gerald W Dorn, Richard N Kitsis, Kinya Otsu, Peipei Ping, Rosario Rizzuto, Michael N Sack, Douglas Wallace, Richard J Youle.
Abstract
Cardiovascular disease is a major leading cause of morbidity and mortality in the United States and elsewhere. Alterations in mitochondrial function are increasingly being recognized as a contributing factor in myocardial infarction and in patients presenting with cardiomyopathy. Recent understanding of the complex interaction of the mitochondria in regulating metabolism and cell death can provide novel insight and therapeutic targets. The purpose of this statement is to better define the potential role of mitochondria in the genesis of cardiovascular disease such as ischemia and heart failure. To accomplish this, we will define the key mitochondrial processes that play a role in cardiovascular disease that are potential targets for novel therapeutic interventions. This is an exciting time in mitochondrial research. The past decade has provided novel insight into the role of mitochondria function and their importance in complex diseases. This statement will define the key roles that mitochondria play in cardiovascular physiology and disease and provide insight into how mitochondrial defects can contribute to cardiovascular disease; it will also discuss potential biomarkers of mitochondrial disease and suggest potential novel therapeutic approaches.Entities:
Keywords: AHA Scientific Statements; calcium; cardiovascular disease; cell death; energetics; metabolism; mitochondria; reactive oxygen species
Mesh:
Year: 2016 PMID: 27126807 PMCID: PMC6398603 DOI: 10.1161/RES.0000000000000104
Source DB: PubMed Journal: Circ Res ISSN: 0009-7330 Impact factor: 17.367